Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?

BACKGROUND: Salvage treatments for recurrent NSCLC after first‐line chemotherapy remain challenging. This study was conducted to evaluate the clinical value of microwave ablation (MWA) and iodine‐125 brachytherapy, including overall survival (OS), disease free survival (DFS), local control, hospital...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorac Cancer
Asıl Yazarlar: Liu, Bin, Wang, Yongzheng, Tian, Shilin, Hertzanu, Yancu, Zhao, Xiaogang, Li, Yuliang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons Australia, Ltd 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049489/
https://ncbi.nlm.nih.gov/pubmed/31995853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13320
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller